AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Mycology Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China

Jian Binga,#Sijia Wanga,#Heping XubShuru FanaHan Dua,cClarissa J. Nobiled,eGuanghua Huanga ( )
Department of Infectious Diseases, Huashan Hospital and State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China
Department of Clinical Laboratory, First Affiliated Hospital of Xiamen University, Xiamen, China
Institutes of Biomedical Sciences, Fudan University, Shanghai, China
Department of Molecular and Cell Biology, University of California, Merced, CA, USA
Health Sciences Research Institute, University of California, Merced, CA, USA

#These authors contributed equally to this work.

Show Author Information

Abstract

The recently emerged fungal pathogen Candida auris often displays resistance to one or more antifungal drugs. Its infections have been identified in at least 40 countries on six continents to date. Here we report a case of C. auris candidemia in a patient in Xiamen, a city in south China. We also review currently reported cases of C. auris infection in China and compare the genetic and biological features of C. auris strains isolated from this country. Our phylogenetic analysis indicates that there are at least two C. auris genetic clades present in China (the South African clade and the south Asian clade) that display opposite mating type loci (one is MTLa and the other is MTLα). We also found that there are several distinct features among the clinical isolates studied, including the expression of virulence factors, antifungal susceptibilities, and cellular morphologies, and that these features could be associated with the mating-type of the isolate. For example, C. auris MTLa isolates generally secreted higher levels of secreted aspartyl proteases (Saps) at ambient environmental temperatures. Taken together, this study demonstrates that C. auris clinical isolates from China exhibit diversity in both biological and genetic features.

References

 

Ahmad S, Alfouzan W. 2021. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 9(4):807. doi:10.3390/microorganisms9040807.

 

Bing J, Hu T, Zheng Q, Munoz JF, Cuomo CA, Huang G. 2020. Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris. Antimicrob Agents Chemother. 65(1):e01466–01420. doi:10.1128/AAC.01466-20.

 

Chen Y, Zhao JY, Han L, Qi LH, Fan WH, Liu J, Wang ZG, Xia X, Chen J, Zhang LL. 2018. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. J Infect. 77(6):569–571. doi:10.1016/j.jinf.2018.09.002.

 

Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. 2019. Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis. 25(9):1780–1781. doi:10.3201/eid2509.190686.

 

Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, et al. 2013. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 19(10):1670–1673. doi:10.3201/eid1910.130393

 

Du H, Bing J, Hu TR, Ennis CL, Nobile CJ, Huang GH. 2020. Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 16(10):e1008921. doi:10.1371/journal.ppat.1008921.

 

Girard V, Mailler S, Chetry M, Vidal C, Durand G, Van Belkum A, Colombo AL, Hagen F, Meis JF, Chowdhary A. 2016. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses. 59(8):535–538. doi:10.1111/myc.12519.

 

Katoh K, Standley DM. 2013. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 30(4):772–780. doi:10.1093/molbev/mst010.

 

Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, et al. 2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 64(2):134–140. doi:10.1093/cid/ciw691

 

Sardi JDO, Silva DR, Mendes-Giannini MJS, Rosalen PL. 2018. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options. Microb Pathog. 125:116–121. doi:10.1016/j.micpath.2018.09.014.

 

Satoh K, Tamura T, Makimura K. 2018. Errata of Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 53(1):41–44. doi:10.1111/j.1348-0421.2008.00083.x.

 

Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 30(9):1312–1313. doi:10.1093/bioinformatics/btu033.

 

Tian S, Rong C, Nian H, Li F, Chu Y, Cheng S, Shang H. 2018. First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China. Emerg Microbes Infect. 7(1):128. doi:10.1038/s41426-018-0131-0.

 

Tian SF, Bing J, Chu YZ, Chen JJ, Cheng ST, Wang QH, Zhang JP, Ma XC, Zhou BS, Liu L, et al. 2021. Genomic epidemiology of Candida auris in a general hospital in Shenyang, China: a three-year surveillance study. Emerging Microbes Infect. 10(1):1088–1096. doi:10.1080/22221751.2021.1934557

 

Tse H, Tsang AKL, Chu YW, Tsang DNC. 2021. Draft genome sequences of 19 clinical isolates of Candida auris from Hong Kong. Microbiol Resour Announc. 10(1):e00308–00320. doi:10.1128/MRA.00308-20.

 

Wang XJ, Bing J, Zheng QS, Zhang FF, Liu JB, Yue HZ, Tao L, Du H, Wang YN, Wang H, et al. 2018. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect. 7(1):93. doi:10.1038/s41426-018-0095-0

Mycology
Pages 68-75
Cite this article:
Bing J, Wang S, Xu H, et al. A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology, 2022, 13(1): 68-75. https://doi.org/10.1080/21501203.2021.1994479

233

Views

13

Crossref

12

Web of Science

14

Scopus

Altmetrics

Received: 30 September 2021
Accepted: 12 October 2021
Published: 31 October 2021
© 2021 The Author(s).

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Return